5-amino-1mq nnmt inhibitor peptide or small molecule 5-Amino-1MQ 50mg | NNMT Inhibitor
Description
Consumers and practitioners may misinterpret GRAS approval as evidence of efficacy, when in fact the obesity trialthe only controlled efficacy studywas negative
are breastfeeding
Store refrigerated at 28 C in a dry, dark environment to support compound stability
Important Notice: 5-Amino-1MQ 5MG is not intended for human or animal use
You just need to relax and get to a fleshy part
In a 12-week randomized clinical trial , subjects receiving AOD 9604 (1 mg/day) lost on average about 2.6 kg , compared with approximately 0.8 kg in the placebo group, suggesting a modest treatment effect on body weight
